Madrigal Pharmaceuticals MDGL Stock
$531.00
-1.062050%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$12.24B
LOW - HIGH [24H]
$526.14
-
$539.07
VOLUME [24H]
$287.88K
P/E Ratio
0
Earnings per share
-$13.33
ISIN
US5588681057
Madrigal Pharmaceuticals Price Chart
Madrigal Pharmaceuticals MDGL Financial and Trading Overview
| Madrigal Pharmaceuticals stock price | 531 USD |
| Previous Close | 560.01 USD |
| Open | 564.94 USD |
| Bid | 552.3 USD x 100 |
| Ask | 537.68 USD x 100 |
| Day's Range | 529.54 - 564.94 USD |
| 52 Week Range | 286.44 - 615 USD |
| Volume | 292.72K USD |
| Avg. Volume | 329.17K USD |
| Market Cap | 12.37B USD |
| Beta (5Y Monthly) | -1.056 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -13.34 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 678.71 USD |
MDGL Valuation Measures
| Enterprise Value | 11.91B USD |
| Trailing P/E | N/A |
| Forward P/E | 43.35218 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.926342 |
| Price/Book (mrq) | 22.755991 |
| Enterprise Value/Revenue | 10.515 |
| Enterprise Value/EBITDA | -38.169 |
Trading Information
Madrigal Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -1.056 |
| 52-Week Change | 77.52% |
| S&P500 52-Week Change | 20.51% |
| 52 Week High | 615 USD |
| 52 Week Low | 286.44 USD |
| 50-Day Moving Average | 511.08 USD |
| 200-Day Moving Average | 499.46 USD |
MDGL Share Statistics
| Avg. Volume (3 month) | 329.17K USD |
| Avg. Daily Volume (10-Days) | 562.54K USD |
| Shares Outstanding | 23.06M |
| Float | 14M |
| Short Ratio | 8.54 |
| % Held by Insiders | 5.67% |
| % Held by Institutions | 106.99% |
| Shares Short | 3.53M |
| Short % of Float | 17.98% |
| Short % of Shares Outstanding | 15.29% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:35 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -27.32% |
| Operating Margin (ttm) | -29.78% |
| Gross Margin | 93.06% |
| EBITDA Margin | -27.55% |
Management Effectiveness
| Return on Assets (ttm) | -17.62% |
| Return on Equity (ttm) | -49.34% |
Income Statement
| Revenue (ttm) | 1.13B USD |
| Revenue Per Share (ttm) | 49.95 USD |
| Quarterly Revenue Growth (yoy) | 126.79% |
| Gross Profit (ttm) | 1.05B USD |
| EBITDA | -311996000 USD |
| Net Income Avi to Common (ttm) | -309436992 USD |
| Diluted EPS (ttm) | -12.93 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 812.77M USD |
| Total Cash Per Share (mrq) | 35.25 USD |
| Total Debt (mrq) | 347.31M USD |
| Total Debt/Equity (mrq) | 63.91 USD |
| Current Ratio (mrq) | 3.495 |
| Book Value Per Share (mrq) | 23.585 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -268096992 USD |
| Levered Free Cash Flow (ttm) | -156403504 USD |
Profile of Madrigal Pharmaceuticals
| Country | United States |
| State | PA |
| City | West Conshohocken |
| Address | Four Tower Bridge |
| ZIP | 19428 |
| Phone | 267 824 2827 |
| Website | https://www.madrigalpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 915 |
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Q&A For Madrigal Pharmaceuticals Stock
What is a current MDGL stock price?
Madrigal Pharmaceuticals MDGL stock price today per share is 531 USD.
How to purchase Madrigal Pharmaceuticals stock?
You can buy MDGL shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Madrigal Pharmaceuticals?
The stock symbol or ticker of Madrigal Pharmaceuticals is MDGL.
Which industry does the Madrigal Pharmaceuticals company belong to?
The Madrigal Pharmaceuticals industry is Biotechnology.
How many shares does Madrigal Pharmaceuticals have in circulation?
The max supply of Madrigal Pharmaceuticals shares is 23.06M.
What is Madrigal Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Madrigal Pharmaceuticals PE Ratio is now.
What was Madrigal Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Madrigal Pharmaceuticals EPS is -13.34 USD over the trailing 12 months.
Which sector does the Madrigal Pharmaceuticals company belong to?
The Madrigal Pharmaceuticals sector is Healthcare.
Madrigal Pharmaceuticals MDGL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25873.18 USD — |
-1.55
|
6.31B USD — | 25822.1 USD — | 26139.37 USD — | — - | 6.31B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
138.78 USD — |
-2.69
|
— — | 138.28 USD — | 141.36 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
12700.6 USD — |
-1.53
|
— — | 12675.61 USD — | 12830.27 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6546.6 USD — |
-1.47
|
— — | 6508.46 USD — | 6585.47 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1254.95 USD — |
-1.05
|
— — | 1250.11 USD — | 1262.34 USD — | — - | — — |
- {{ link.label }} {{link}}